CELU Celularity Inc.
Healthcare$0.90+3.08%ClosedMarket Cap: $21.6M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.59
P/S
0.79
EV/EBITDA
-0.72
DCF Value
$-14.70
FCF Yield
-63.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
76.0%
Operating Margin
-230.9%
Net Margin
-345.4%
ROE
411.5%
ROA
-85.5%
ROIC
-151.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $4.1M | 208.5% | $-22.1M | $-24.4M | $— | — |
| FY null | $26.6M | 76.0% | $-61.3M | $-91.8M | $— | — |
| Q3 null | $5.3M | 61.8% | $-12.9M | $-23.1M | $— | — |
| Q2 null | $5.7M | 8.6% | $-15.9M | $-24.5M | $— | — |
| Q1 null | $11.4M | 68.9% | $-10.5M | $-19.8M | $— | — |
| Q4 null | $18.1M | 59.5% | $-9.3M | $-13.3M | $— | — |
| FY null | $54.2M | 72.4% | $-38.4M | $-57.9M | $— | — |
| Q3 null | $9.3M | 58.2% | $-11.5M | $-16.1M | $— | — |
| Q2 null | $12.1M | 82.5% | $-10.2M | $-6.5M | $— | — |
| Q1 null | $14.7M | 88.8% | $-7.4M | $-22.0M | $— | — |
| Q4 null | $12.1M | 20.7% | $13.3M | $9.5M | $— | — |
| FY null | $22.8M | 29.7% | $-192.3M | $-196.3M | $— | — |